123 related articles for article (PubMed ID: 7774654)
21. Relative importance of C3b inactivator and beta 1H globulin in the modulation of the properdin amplification loop in systemic lupus erythematosus.
Whaley K; Schur PH; Ruddy S
Clin Exp Immunol; 1979 Jun; 36(3):408-14. PubMed ID: 114347
[TBL] [Abstract][Full Text] [Related]
22. The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway.
Hung SL; Peng C; Kostavasili I; Friedman HM; Lambris JD; Eisenberg RJ; Cohen GH
Virology; 1994 Sep; 203(2):299-312. PubMed ID: 8053154
[TBL] [Abstract][Full Text] [Related]
23. Activated factor B (Bb) of the alternative pathway of complement activation cleaves and activates plasminogen.
Sundsmo JS; Wood LM
J Immunol; 1981 Sep; 127(3):877-80. PubMed ID: 6911148
[TBL] [Abstract][Full Text] [Related]
24. C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.
Whaley K; Schur PH; Ruddy S
J Clin Invest; 1976 Jun; 57(6):1554-63. PubMed ID: 819459
[TBL] [Abstract][Full Text] [Related]
25. Interaction of C3b(2)--IgG complexes with complement proteins properdin, factor B and factor H: implications for amplification.
Jelezarova E; Vogt A; Lutz HU
Biochem J; 2000 Jul; 349(Pt 1):217-23. PubMed ID: 10861231
[TBL] [Abstract][Full Text] [Related]
26. Mapping of the properdin-binding site in the third component of complement.
Lambris JD; Alsenz J; Schulz TF; Dierich MP
Biochem J; 1984 Jan; 217(1):323-6. PubMed ID: 6696726
[TBL] [Abstract][Full Text] [Related]
27. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae.
Densen P; McRill CM; Ross SC
J Immunol; 1988 Dec; 141(11):3902-9. PubMed ID: 3141507
[TBL] [Abstract][Full Text] [Related]
28. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
Kozlov LV; Shibanova ED; Zinchenko AA
Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
[TBL] [Abstract][Full Text] [Related]
29. Binding of properdin to solid-phase immune complexes: critical role of the classical activation pathway of complement.
Junker A; Baatrup G; Svehag SE; Wang P; Holmström E; Sturfelt G; Sjöholm AG
Scand J Immunol; 1998 May; 47(5):481-6. PubMed ID: 9627133
[TBL] [Abstract][Full Text] [Related]
30. C3 binds covalently to the C gamma 3 domain of IgG immune aggregates during complement activation by the alternative pathway.
Antón LC; Alcolea JM; Sánchez-Corral P; Marqués G; Sánchez A; Vivanco F
Biochem J; 1989 Feb; 257(3):831-8. PubMed ID: 2784671
[TBL] [Abstract][Full Text] [Related]
31. C3b2-IgG complexes retain dimeric C3 fragments at all levels of inactivation.
Jelezarova E; Luginbuehl A; Lutz HU
J Biol Chem; 2003 Dec; 278(51):51806-12. PubMed ID: 14527961
[TBL] [Abstract][Full Text] [Related]
32. Activation, binding, and processing of complement component 3 (C3) by Blastomyces dermatitidis.
Zhang MX; Klein B
Infect Immun; 1997 May; 65(5):1849-55. PubMed ID: 9125571
[TBL] [Abstract][Full Text] [Related]
33. Properdin binding to complement activating surfaces depends on initial C3b deposition.
Harboe M; Johnson C; Nymo S; Ekholt K; Schjalm C; Lindstad JK; Pharo A; Hellerud BC; Nilsson Ekdahl K; Mollnes TE; Nilsson PH
Proc Natl Acad Sci U S A; 2017 Jan; 114(4):E534-E539. PubMed ID: 28069958
[TBL] [Abstract][Full Text] [Related]
34. Activation of the alternative pathway of human complement by apoptotic human umbilical vein endothelial cells.
Tsuji S; Kaji K; Nagasawa S
J Biochem; 1994 Oct; 116(4):794-800. PubMed ID: 7883753
[TBL] [Abstract][Full Text] [Related]
35. Alternative pathway of complement: demonstration and characterization of initiating factor and its properdin-independent function.
Schreiber RD; Götze O; Müller-Eberhard HJ
J Exp Med; 1976 Oct; 144(4):1062-75. PubMed ID: 62010
[TBL] [Abstract][Full Text] [Related]
36. Activation of the alternative pathway of human complement by autologous cells expressing transmembrane recombinant properdin.
Vuagnat BB; Mach J; Le Doussal JM
Mol Immunol; 2000 Jun; 37(8):467-78. PubMed ID: 11090881
[TBL] [Abstract][Full Text] [Related]
37. Linkage specificity and role of properdin in activation of the alternative complement pathway by fungal glycans.
Agarwal S; Specht CA; Haibin H; Ostroff GR; Ram S; Rice PA; Levitz SM
mBio; 2011; 2(5):. PubMed ID: 21878570
[TBL] [Abstract][Full Text] [Related]
38. Expression and characterisation of the thrombospondin type I repeats of human properdin.
Perdikoulis MV; Kishore U; Reid KB
Biochim Biophys Acta; 2001 Aug; 1548(2):265-77. PubMed ID: 11513971
[TBL] [Abstract][Full Text] [Related]
39. Properdin binds to late apoptotic and necrotic cells independently of C3b and regulates alternative pathway complement activation.
Xu W; Berger SP; Trouw LA; de Boer HC; Schlagwein N; Mutsaers C; Daha MR; van Kooten C
J Immunol; 2008 Jun; 180(11):7613-21. PubMed ID: 18490764
[TBL] [Abstract][Full Text] [Related]
40. The role of properdin in zymosan- and Escherichia coli-induced complement activation.
Harboe M; Garred P; Lindstad JK; Pharo A; Müller F; Stahl GL; Lambris JD; Mollnes TE
J Immunol; 2012 Sep; 189(5):2606-13. PubMed ID: 22851705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
